My HPRA: Register

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Nurofen Rapid Relief Max 400 mg soft capsules



Reckitt Benckiser Ireland LtdPA0979/085/001

Main Information

Trade NameNurofen Rapid Relief Max 400 mg soft capsules
Active SubstancesIbuprofen
Dosage FormCapsule, soft
Licence HolderReckitt Benckiser Ireland Ltd
Licence NumberPA0979/085/001

Group Information

ATC CodeM01AE01 ibuprofen

Status

License statusAuthorised
Licence Issued25/08/2023
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of LicenceProduct not subject to medical prescription, supply through pharmacies only and promotion to the public subject to the following restrictions: maximum strength 400 mg, maximum pack size 24, maximum dose: 400 mg, maximum daily dose 1200 mg, limited indications. For use in adults and children over 12 years.
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back
Follow medicine

Print